![](/img/cover-not-exists.png)
Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial
Pinder, S E, Campbell, A F, Bartlett, J M S, Marshall, A, Allen, D, Falzon, M, Dunn, J A, Makris, A, Hughes-Davies, L, Stein, R CVolume:
116
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2017.28
Date:
March, 2017
File:
PDF, 111 KB
english, 2017